Aspirin for the prevention of colorectal cancer
Nakamura Masato
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 42(11): 1357-1362
2015
ISSN/ISBN: 0385-0684 PMID: 26841454 Document Number: 684023
Document emailed within 1 workday
Related Documents
Smith, D.K.; Demetriou, T.; Weber, C. 2019: Aspirin for primary prevention: USPSTF recommendations for CVD and colorectal cancer Journal of Family Practice 68(3): 146-151Owens, D.K. 2017: Aspirin for the Prevention of Cardiovascular Disease and Colorectal Cancer: New Recommendations from the USPSTF American Family Physician 95(4): 222-223
Schuler, M. 1996: Aspirin and the risk of colorectal cancer in women New England Journal of Medicine 334(2): 121-122
Farmer, K.C.; Goulston, K.; Macrae, F. 1993: Aspirin and non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer Medical Journal of Australia 159(10): 649-650
Benamouzig, R. 1998: Do aspirin or nonsteroidal anti-inflammatory drugs decrease the risk of colorectal cancer? Gastroenterologie Clinique et Biologique 22(3 Suppl): S22-S27
Gaciong, Z. 2006: Clopidogrel and aspirin versus aspirin alone in prevention of atherothrombotic events. The results of CHARISMA study Kardiologia Polska 64(5): 548
Selak, V.; Jackson, R.; Poppe, K.; Kerr, A.; Wells, S. 2018: Are the benefits of aspirin likely to exceed the risk of major bleeds among people in whom aspirin is recommended for the primary prevention of cardiovascular disease? New Zealand Medical Journal 131(1484): 19-25
Young, F.E.; Nightingale, S.L.; Temple, R.A. 1988: The preliminary report of the findings of the aspirin component of the ongoing Physicians' Health Study. The FDA perspective on aspirin for the primary prevention of myocardial infarction JAMA 259(21): 3158-3160
Greene, P.; Mays, G.; Kim, K.; Hager, B.; Goldsmith, G.; Bursac, Z.; Carter, D.; Duke, K.; Mehta, P.; Tillman, R.Henry. 2009: Colorectal cancer screening in Arkansas: implications for cancer prevention in primary care Journal of the Arkansas Medical Society 106(3): 66-68
Bolin, T.; Cowen, A.E.; Korman, M.G. 2002: Colorectal cancer prevention Medical Journal of Australia 176(4): 145-146
Faivre, J.; Couillault, C.; Belghiti, C. 1996: Intervention trials on colorectal cancer prevention Iarc Scientific Publications 1996(139): 115-124
Ahlquist, D.A. 2002: Colorectal cancer prevention and detection. Introduction Gastroenterology clinics of North America 31(4): xi-xii
Faivre, J.; Hofstad, B.; Bonelli, L.; Rooney, P.; Couillault, C. 1996: European intervention trials of colorectal cancer prevention Iarc Scientific Publications 1996(136): 45-51
Schrag, D.; Weeks, J. 1999: Costs and cost-effectiveness of colorectal cancer prevention and therapy Seminars in Oncology 26(5): 561-568
Chepyala, P.; Aduli, F.; Olden, K.W. 2008: Primary prevention of colorectal cancer: an evidence-based approach Journal of the Arkansas Medical Society 104(12): 290-292
Ranger, G.Singh. 2014: Current concepts in colorectal cancer prevention with cyclooxygenase inhibitors Anticancer Research 34(11): 6277-6282
Penna, C.P.; Tiret, E.; Kartheuser, A.H.; Olschwang, S.; Parc, R. 1992: Value of screening of familial adenomatous polyposis for the prevention of colorectal cancer Gastroenterologie Clinique et Biologique 16(3): 210-214
Aaltonen, L.A.; Sankila, R.; Mecklin, J.P.; Järvinen, H.; Pukkala, E.; Peltomäki, P.; de la Chapelle, A. 1994: A novel approach to estimate the proportion of hereditary nonpolyposis colorectal cancer of total colorectal cancer burden Cancer Detection and Prevention 18(1): 57-63
Szmidt, M.; Grzelewska-Rzymowska, I.; Rozniecki, J.; Grzegorczyk, J. 1991: Neutrophil chemotactic activity after administration of aspirin during aspirin tolerance in patients with asthma and aspirin hypersensitivity Pneumonologia i Alergologia Polska 59(1-2): 16-21
Yokoyama, T.; Yamashita, K.; Yamasaki, F.; Ueta, T.; Manabe, M.; Nishiyama, T. 2003: Aspirin reversal--an incremental administration of aspirin shortens the bleeding time prolonged by low-dose aspirin Masui. Japanese Journal of Anesthesiology 52(4): 399-401